A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial)

This prospective study aimed to develop reproducible diagnostic criteria for sporadic Burkitt lymphoma (BL), applicable to routine practice, and to evaluate the efficacy of dose-modified (dm) CODOX-M/IVAC in patients diagnosed using these criteria. The study was open to patients with an aggressive B...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Mead, Graham M., Barrans, Sharon L., Qian, Wendi, Walewski, Jan, Radford, John A., Wolf, Max, Clawson, Simon M., Stenning, Sally P., Yule, Claire L., Jack, Andrew S.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2008
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2532802/
https://ncbi.nlm.nih.gov/pubmed/18612102
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-03-145128
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados